The reason is US pharmacy law
Natalie Allen , RD, is a clinical assistant professor of nutrition and dietetics at Missouri State University
Not because you want to, but because the pricing landscape is deliberately opaque
Biosimilar Approvals, by Product Type, 2015 to 2025 Exhibit 259: Physician Perceptions of Biosimilars, by Specialty, 2023 Exhibit 260: Formulary Coverage for Humira and Its Biosimilars, by PBM, 2025 Exhibit 261: Formulary Coverage and Pricing for Stelara and Its Biosimilars, by PBM, 2026 Exhibit 262: Top Specialty Therapy Categories, Generic Drugs as a Share of Prescriptions and Net Spending, 2025 Exhibit 263: Nonbiological Specialty Drugs, Pharmacy Acquisition Cost per Unit for Brand-Name vs
Why Choose Revital Trichology
- Supports hair regrowth and thickens thinning areas